Profile data is unavailable for this security.
About the company
HeiLongJiang ZBD Pharmaceutical Co Ltd is a China-based company engaged in the research, development, production and sale of pharmaceuticals. The primary products include active pharmaceutical ingredients, chemical preparations, traditional Chinese medicine preparations and biologics, primarily for cardiovascular, antiviral, respiratory, pediatric and traditional Chinese medicine applications. The Company is also engaged in pharmaceutical and traditional Chinese medicine trading. The Company mainly conducts its businesses in the domestic market.
- Revenue in CNY (TTM)1.60bn
- Net income in CNY-332.62m
- Incorporated1996
- Employees2.35k
- LocationHeiLongJiang ZBD Pharmaceutical Co LtdNo. 8Yantai First Road, Pingfang DistrictHAERBIN 150060ChinaCHN
- Phone+86 45 186811969
- Fax+86 45 187105767
- Websitehttps://www.zbdzy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Aidea Pharmaceutical Group Co Ld | 671.33m | -87.10m | 7.36bn | 704.00 | -- | 7.53 | -- | 10.97 | -0.207 | -0.207 | 1.60 | 2.32 | 0.3558 | 1.01 | 4.33 | 953,592.70 | -3.23 | -4.33 | -5.23 | -5.36 | 63.08 | 40.16 | -9.09 | -20.35 | 1.03 | -2.12 | 0.3093 | -- | 1.57 | 3.89 | -85.63 | -- | 5.88 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.78bn | 214.11m | 7.39bn | 3.63k | 34.43 | 1.77 | -- | 1.96 | 0.2112 | 0.2112 | 3.72 | 4.12 | 0.633 | 3.37 | 7.63 | 1,040,448.00 | 4.45 | 0.7994 | 6.29 | 5.29 | 51.41 | 23.96 | 7.02 | 3.71 | 3.96 | -- | 0.0393 | 43.21 | -13.02 | -17.29 | -19.73 | -6.70 | 21.16 | 0.00 |
| Wuhan Keqian Biology Co Ltd | 1.01bn | 459.54m | 7.57bn | 924.00 | 16.57 | 1.81 | -- | 7.46 | 0.9796 | 0.9796 | 2.16 | 8.95 | 0.2209 | 2.86 | 3.23 | 1,097,706.00 | 9.97 | 11.71 | 11.17 | 13.56 | 65.26 | 73.57 | 45.16 | 44.51 | 5.02 | -- | 0.0017 | 32.23 | -11.48 | 13.17 | -3.43 | 9.52 | -4.93 | -- |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 1.60bn | -332.62m | 7.65bn | 2.35k | -- | 1.05 | -- | 4.79 | -0.3545 | -0.3545 | 1.70 | 7.75 | 0.1303 | 0.6358 | 0.4977 | 679,399.90 | -2.74 | 3.29 | -3.80 | 4.46 | 44.16 | 37.24 | -21.03 | 10.59 | 1.33 | -1.45 | 0.3114 | 24.43 | -13.90 | -3.87 | -7.30 | 1.41 | 1.13 | -7.12 |
| Cisen Pharmaceutical Co Ltd | 3.56bn | 492.80m | 7.76bn | 3.30k | 15.81 | 1.26 | -- | 2.18 | 1.08 | 1.08 | 7.84 | 13.59 | 0.472 | 2.10 | 5.34 | 1,079,074.00 | 6.58 | 6.51 | 8.12 | 8.07 | 53.70 | 55.92 | 13.94 | 10.84 | 3.48 | -- | 0.0069 | 37.16 | -10.77 | -0.6464 | -2.38 | -0.2215 | -0.3051 | 10.42 |
| China Animal Husbandry Industry Co., Ltd | 6.28bn | 214.44m | 7.83bn | 4.30k | 36.52 | 1.37 | -- | 1.25 | 0.21 | 0.21 | 6.15 | 5.60 | 0.6863 | 5.30 | 4.19 | 1,461,064.00 | 2.32 | 5.25 | 3.37 | 7.48 | 15.59 | 22.15 | 3.38 | 7.31 | 1.62 | -- | 0.1625 | 31.16 | 11.30 | 7.79 | -82.41 | -22.24 | -0.0699 | -21.83 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 751.12m | 184.84m | 7.97bn | 1.22k | 42.83 | 3.40 | -- | 10.61 | 0.2241 | 0.2241 | 0.8963 | 2.83 | 0.2472 | 0.9248 | 3.00 | 616,180.10 | 6.08 | 8.91 | 7.77 | 12.10 | 51.51 | 53.44 | 24.61 | 27.68 | 2.17 | -- | 0.1383 | 27.35 | -2.63 | 20.90 | -18.55 | 29.68 | 17.53 | 43.79 |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.29bn | -363.56m | 8.06bn | 2.97k | -- | 1.39 | -- | 3.51 | -0.1112 | -0.1112 | 0.7189 | 1.82 | 0.204 | 2.09 | 3.30 | 771,487.60 | -4.90 | -0.1745 | -7.79 | -0.2739 | 34.13 | 64.36 | -24.05 | -0.6631 | 2.01 | -5.26 | 0.2563 | 69.54 | -26.67 | -9.85 | -547.14 | -- | 4.41 | -- |
| Changchun BCHT Biotechnology Co | 677.51m | -170.53m | 8.07bn | 1.27k | -- | 2.04 | -- | 11.92 | -0.4124 | -0.4124 | 1.64 | 9.57 | 0.1288 | 0.7183 | 0.4756 | 531,801.10 | -3.24 | 8.14 | -4.12 | 10.19 | 77.22 | 85.58 | -25.17 | 23.29 | 1.20 | -8.89 | 0.0696 | 14.91 | -32.64 | 4.73 | -53.67 | 0.9824 | 33.40 | -- |
Data as of Feb 13 2026. Currency figures normalised to HeiLongJiang ZBD Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 2.69m | 0.29% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.31m | 0.25% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.60m | 0.17% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.54m | 0.16% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.30m | 0.14% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 1.12m | 0.12% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 947.50k | 0.10% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 861.40k | 0.09% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 845.10k | 0.09% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 521.00k | 0.06% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
